Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements.
作者： Alain Bitton , Donald Buie , Robert Enns , Brian G Feagan , Jennifer L Jones
DOI: 10.1038/AJG.2011.386
关键词: Internal medicine 、 Ulcerative colitis 、 MEDLINE 、 Colitis 、 Medicine 、 Gastroenterology 、 Treatment outcome 、 Infliximab 、 Adult patients
摘要: Treatment of Hospitalized Adult Patients With Severe Ulcerative Colitis: Toronto Consensus Statements
nature.com
medlive.cn 参考文章(157)
S P Travis, J M Farrant, C Ricketts, D J Nolan, N M Mortensen, M G Kettlewell, D P Jewell, Predicting outcome in severe ulcerative colitis. Gut. ,vol. 38, pp. 905- 910 ,(1996) , 10.1136/GUT.38.6.905
CSJ Probert, SD Hearing, S Schreiber, T Kühbacher, S Ghosh, IDR Arnott, A Forbes, Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial Gut. ,vol. 52, pp. 998- 1002 ,(2003) , 10.1136/GUT.52.7.998
J. Ramakrishna, N. Langhans, K. Calenda, R. J. Grand, M. Verhave, Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition. ,vol. 22, pp. 296- 302 ,(1996) , 10.1097/00005176-199604000-00012
Gerald H Mazurek, Beverly Metchock, Andrew Vernon, Michael F Iademarco, John Jereb, Phillip Lobue, Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. ,vol. 54, pp. 49- 55 ,(2005)
RW Chapman, WS Selby, DP Jewell, None, Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut. ,vol. 27, pp. 1210- 1212 ,(1986) , 10.1136/GUT.27.10.1210
Janak Kishore, Ujjala Ghoshal, Uday C Ghoshal, Narendra Krishnani, Sanjay Kumar, Manisha Singh, Archana Ayyagari, Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. Journal of Medical Microbiology. ,vol. 53, pp. 1155- 1160 ,(2004) , 10.1099/JMM.0.45629-0
David N. Moskovitz, Gert Van Assche, Benedikte Maenhout, Joris Arts, Marc Ferrante, Severine Vermeire, Paul Rutgeerts, Incidence of Colectomy During Long-term Follow-up After Cyclosporine-Induced Remission of Severe Ulcerative Colitis Clinical Gastroenterology and Hepatology. ,vol. 4, pp. 760- 765 ,(2006) , 10.1016/J.CGH.2006.04.001
Elana A. Maser, Deepthi Deconda, Simon Lichtiger, Thomas Ullman, Daniel H. Present, Asher Kornbluth, Cyclosporine and Infliximab as Rescue Therapy for Each Other in Patients With Steroid-Refractory Ulcerative Colitis Clinical Gastroenterology and Hepatology. ,vol. 6, pp. 1112- 1116 ,(2008) , 10.1016/J.CGH.2008.04.035
Asher Kornbluth, David B Sachar, Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. The American Journal of Gastroenterology. ,vol. 105, pp. 501- 523 ,(2010) , 10.1038/AJG.2009.727
F. Anderson Rowe, John H. Walker, Loren C. Karp, Eric A. Vasiliauskas, Scott E. Plevy, Stephan R. Targan, Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis. The American Journal of Gastroenterology. ,vol. 95, pp. 2000- 2008 ,(2000) , 10.1111/J.1572-0241.2000.02186.X